ST JOHN'S, Antigua, June 15 /PRNewswire/ --

- Renowned Bodog.com Domain Becomes Brand's Global Portal

Bodog Europe joins Bodog Asia and the Morris Mohawk Gaming Group in celebrating the triumphant return of http://www.bodog.com as the Bodog brand's global online portal. Bodog's US brand licensee, the Morris Mohawk Gaming Group, acquired the domain earlier this year and will be operating its site at that URL. However, the world-renowned http://www.bodog.com domain will be the global portal for all brand licensees worldwide.

INDIANAPOLIS, June 15 /PRNewswire/ --

- Goal is to foster open collaboration between Lilly and global laboratory researchers

Alzheimer's disease. Cancer. Diabetes. Osteoporosis.

These are the diseases for which Eli Lilly and Company will be engaging researchers from around the world in a new and unique drug discovery initiative.

The initiative, called the Lilly Phenotypic Drug Discovery Initiative, or PD2 (pronounced PD-squared)*, uses Lilly-developed disease-state assays and a secure web portal to evaluate the therapeutic potential of compounds synthesized in university and biotechnology laboratories. Findings from this initiative could ultimately form the basis for collaboration or licensing agreements between Lilly and external institutions.

AMSTERDAM, June 15 /PRNewswire/ -- Ticket Service Nederland, a Ticketmaster Entertainment, Inc., (NASDAQ:TKTM) operating business, Paradiso corporation and Melkweg corporation today announced a multi-year extension of their more than decade-long ticketing partnership. The agreement extends Ticketmaster's exclusive ticketing for Paradiso and Melkweg (Milkyway) for all Events taking place in these Music Venues. Both multi-purpose Venues are situated in the very centre of Amsterdam and are renowned worldwide for their ambiance supplying the ultimate live Music experience for over 1.000.000 enthusiastic visitors yearly.

WELLESLEY HILLS, Massachusetts, June 15 /PRNewswire/ --

Joseph F. Finn, Jr., C.P.A. (Finn) announced today that in vitro studies have demonstrated that GCS-100 binds to and blocks the effects of galectin-3. Galectin-3 plays an important role in tumor cell survival, new blood vessel growth, cell proliferation and tumor metastasis, which is the spread of cancer beyond its primary site. As a result, this product candidate may have multiple benefits in combating cancer cells, including:

- Induction of apoptosis

- Inhibition of angiogenesis

- Inhibition of cancer cell proliferation

- Inhibition of metastasis

SAO PAULO, June 15 /PRNewswire/ --

- The world's most important event for the health ingredients industry arrives in Brazil

The leaders in the health ingredients industry have arrived in Brazil today for the Health ingredients South America (HiSA) Summit. Over the next two days, industry players will take full advantage of this opportunity to network, promote their products and services and most importantly, explore the opportunities in this dynamic emerging market.

The major players are heading south

BOSTON, June 15 /PRNewswire/ --

- Study Shows Kowa's Novel Synthetic Statin is Safe and Well Tolerated in Combination With Warfarin

New data presented today showed that pitavastatin may provide a new treatment option for patients with dyslipidaemia and complex issues, such as those on multiple medications, as evidenced by a study supporting pitavastatin's potential for low drug-drug interaction. The data were presented today by Kowa at the XV International Symposium on Atherosclerosis in Boston.

BEAVERTON, Oregon, June 15 /PRNewswire/ --

- Unique Design Provides Ultra-Thin Profile and Uninterrupted Operation for European Customers

HONG KONG, June 15 /PRNewswire/ --

Strong balance sheet to ride out global economic downturn -- Group revenue decreased by 6.7% to US$1,448.2 million -- Profit attributable to shareholders declined by 33.6% to US$143.2 million -- Final dividend of US41.0 cents per ordinary share -- Net cash position of US$287.2 million, as compared to US$285.4 million in the last financial year

VTech Holdings Ltd (HKSE: 303; ADR: VTKHY) today announced its annual results for the year ended 31st March 2009, reporting lower revenue and profit. Despite this, the Group's balance sheet remains strong with the net cash position as at 31st March 2009 increased from US$285.4 million to US$287.2 million.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090615/HKM004 )

MANCHESTER, England, June 15 /PRNewswire/ --

- 93% of Large Enterprise IT Administrators Say There is No Risk from Former Employees; Yet More than Half Have Limited Knowledge of Employee Access Rights to Systems

Courion(R) Corporation, leaders in access governance, provisioning and compliance, today releases survey results revealing that while a vast majority (93%) of organisations are confident that terminated employees pose no security risk to their systems by virtue of legacy access, many have limited or no knowledge of the systems to which their active and terminated employees have access. This unwarranted confidence in system security leaves companies vulnerable to attacks that could cost millions.

Do you have what it takes to be Scientific Blogging's alpha geek? Well it’s time put your geek where your mouth is…IF YOU CAN!

But first a warning: yes, you could Google for these answers, but then,  deep down, you’ll know you’re a bad person. Then again, you might win a free Geeks’ Guide to World Domination.

So you’ll have to balance total loss of self worth with free geek schwag. It’s up to you.

Email your answers to geekoff@gmail.com. DON'T COMMENT YOUR ANSWERS or you will allow slackers to water down the winner’s pool, thus decreasing your chances of receiving said geek schwag (and you’ll get moderated, deserve a spanking, be summarily executed, etc.).